Henry Schein (HSIC) Shares Outstanding (Diluted Average) (2009 - 2026)
Henry Schein (HSIC) recorded quarterly Shares Outstanding (Diluted Average) of $116.1 million in Q1 2026, down 4.65% quarter-over-quarter from $121.7 million in Q4 2025, and down 7.04% on a YoY basis from $124.8 million in Q1 2025.
Henry Schein (HSIC) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Henry Schein's Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $116.1 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 7.04% year-over-year to $116.1 million; the TTM figure through Mar 2026 stood at $116.1 million (down 7.04% YoY), while the FY2025 annual figure was $121.7 million, down 4.74% from the prior year.
- Shares Outstanding (Diluted Average) was $116.1 million for Q1 2026 at Henry Schein, down from $121.7 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $139.1 million in Q2 2022 to a low of $116.1 million in Q1 2026.
- Historically, Shares Outstanding (Diluted Average) has averaged $129.1 million across 5 years, with a median of $129.5 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) decreased 2.46% in 2024, then slipped 7.04% in 2026.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $137.8 million in 2022, then retreated by 4.36% to $131.7 million in 2023, then declined by 3.01% to $127.8 million in 2024, then decreased by 4.74% to $121.7 million in 2025, then dropped by 4.65% to $116.1 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $116.1 million (Q1 2026), $121.7 million (Q4 2025), and $122.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1.00 |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 124.10 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 195.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 236.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 116.06 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 116.06 Mn |
| Dec 27, 2025 | 121.72 Mn |
| Sep 27, 2025 | 122.84 Mn |
| Jun 28, 2025 | 123.74 Mn |
| Mar 29, 2025 | 124.85 Mn |
| Dec 28, 2024 | 127.78 Mn |
| Sep 28, 2024 | 127.05 Mn |
| Jun 29, 2024 | 129.21 Mn |
| Mar 30, 2024 | 129.77 Mn |
| Dec 30, 2023 | 131.75 Mn |
| Sep 30, 2023 | 132.15 Mn |
| Jul 1, 2023 | 132.47 Mn |
| Apr 1, 2023 | 133.04 Mn |
| Dec 31, 2022 | 137.76 Mn |
| Sep 24, 2022 | 137.08 Mn |
| Jun 25, 2022 | 139.06 Mn |
| Dec 25, 2021 | 141.77 Mn |
| Sep 25, 2010 | 93,098.00 |
| Jun 26, 2010 | 93,352.00 |
| Sep 26, 2009 | 90,576.00 |